Dagmar Berghuis

1.0k total citations
23 papers, 586 citations indexed

About

Dagmar Berghuis is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Dagmar Berghuis has authored 23 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Oncology and 7 papers in Hematology. Recurrent topics in Dagmar Berghuis's work include Immunodeficiency and Autoimmune Disorders (6 papers), Immune Cell Function and Interaction (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Dagmar Berghuis is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (6 papers), Immune Cell Function and Interaction (6 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Dagmar Berghuis collaborates with scholars based in Netherlands, Italy and Germany. Dagmar Berghuis's co-authors include Arjan C. Lankester, Pancras C.W. Hogendoorn, Marco W. Schilham, R. Maarten Egeler, Susy J. Santos, Antonïe H.M. Taminiau, Emilie P. Buddingh, Hans J. Baelde, Károly Szuhai and Mirjam van der Burg and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Dagmar Berghuis

20 papers receiving 582 citations

Peers

Countries citing papers authored by Dagmar Berghuis

Since Specialization

Citations

This map shows the geographic impact of Dagmar Berghuis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Berghuis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Berghuis more than expected).

Fields of papers citing papers by Dagmar Berghuis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Berghuis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Berghuis. The network helps show where Dagmar Berghuis may publish in the future.

Co-authorship network of co-authors of Dagmar Berghuis

This figure shows the co-authorship network connecting the top 25 collaborators of Dagmar Berghuis. A scholar is included among the top collaborators of Dagmar Berghuis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagmar Berghuis. Dagmar Berghuis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical challenges following early detection of ataxia telangiectasia through SCID newborn screening 2025 ·SHILAP Revista de lepidopterología ·(unknown), Dagmar Berghuis, Maartje Blom, Michèl A.A.P. Willemsen, Mirjam van der Burg	0
2	RAG1 lentiviral gene therapy restores T-cell development of RAG1-SCID patient cells in artificial thymic organoids 2025 ·Blood Advances ·(unknown), Janine Melsen, (unknown), (unknown), Sandra A. Vloemans, (unknown), Dagmar Berghuis, Arjan C. Lankester, Sander de Kivit, Karin Pike‐Overzet, Anton W. Langerak, Frank J. T. Staal, (unknown), Kirsten Canté-Barrett	0
3	Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency—Centromeric Instability—Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study 2024 ·Journal of Clinical Immunology ·Dagmar Berghuis, (unknown), Rolla Abu‐Arja, Michael H. Albert, (unknown), Horst von Bernuth, Reem Elfeky, Philippe Lewalle, Alexandra Laberko, Sujal Ghosh, Mary Slatter, Corry M.R. Weemaes, Akif Yeşilipek, Tiarlan Sirait, Bénédicte Neven, Andrew R. Gennery, Arjan C. Lankester, (unknown)	0
4	Restoration of T and B Cell Differentiation after RAG1 Gene Transfer in Human RAG1 Defective Hematopoietic Stem Cells 2024 ·Biomedicines ·(unknown), Francisco Díaz-Pascual, (unknown), Hanem Sadek, (unknown), (unknown), (unknown), Irene Gil-Fariña, (unknown), (unknown), Dagmar Berghuis, Arjan C. Lankester, Isabelle André‐Schmutz, (unknown), Marina Cavazzana, (unknown), Frank J. T. Staal, Chantal Lagresle‐Peyrou	3
5	Clinical phenotype of FOXP1 syndrome: parent-reported medical signs and symptoms in 40 individuals 2023 ·Journal of Medical Genetics ·Saskia Koene, (unknown), (unknown), (unknown), (unknown), Dagmar Berghuis, Angela Morgan, M. Pilar Trelles, Jeroen R. Scheepe, Regina Bökenkamp, Cacha Peeters‐Scholte, Ruth Braden, Gijs W.E. Santen	4
6	Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell Defect 2023 ·International Journal of Molecular Sciences ·Lisa M. Ott de Bruin, Ingrid Pico‐Knijnenburg, Monique M. van Ostaijen-ten Dam, (unknown), Dagmar Berghuis, Robbert G. M. Bredius, Arjan C. Lankester, Mirjam van der Burg	2
7	Identification of Treosulfan-Induced Myalgia in Pediatric Hematopoietic Stem Cell Transplantation Using an Electronic Health Record Text Mining Tool 2021 ·Transplantation and Cellular Therapy ·(unknown), Dagmar Berghuis, (unknown), Emilie P. Buddingh, (unknown), Frans J. Smiers, Henk‐Jan Guchelaar, Arjan C. Lankester, J. Zwaveling	2
8	Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study 2021 ·Transplantation and Cellular Therapy ·(unknown), Alice Bertaina, Dirk Jan A. R. Moes, Mattia Algeri, Robbert G. M. Bredius, Frans J. Smiers, Dagmar Berghuis, Emilie P. Buddingh, Alexander B. Mohseny, Henk‐Jan Guchelaar, Franco Locatelli, J. Zwaveling, Arjan C. Lankester	15
9	Modeling Influencing Factors in B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation in Children 2021 ·Frontiers in Immunology ·(unknown), (unknown), Dagmar Berghuis, Pauline A. van Schouwenburg, Hein Putter, Mirjam van der Burg, Arjan C. Lankester	6
10	Treosulfan-induced myalgia in pediatric hematopoietic stem cell transplantation identified by an electronic health record text mining tool 2021 ·Scientific Reports ·(unknown), Dagmar Berghuis, Robbert G. M. Bredius, Emilie P. Buddingh, Alexander B. Mohseny, Frans J. Smiers, Henk‐Jan Guchelaar, Arjan C. Lankester, J. Zwaveling	3
11	Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment during Hematopoietic Stem Cell Transplantation 2019 ·Biology of Blood and Marrow Transplantation ·Vincent Bekker, Romy D. Zwittink, Cornelis W. Knetsch, Ingrid M. J. G. Sanders, Dagmar Berghuis, Peter J. Heidt, Jaak M. Vossen, Willem M. de Vos, Clara Belzer, Robbert G. M. Bredius, (unknown), Arjan C. Lankester, Ed J. Kuijper	13
12	B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children 2019 ·Frontiers in Immunology ·(unknown), Dagmar Berghuis, Mirjam van der Burg, Arjan C. Lankester	40
13	Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy 2016 ·Cancer Immunology Immunotherapy ·(unknown), Dagmar Berghuis, Károly Szuhai, Pancras C.W. Hogendoorn	14
14	CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients 2015 ·European Journal of Cancer ·(unknown), Katia Scotlandi, Dagmar Berghuis, B. Ewa Snaar‐Jagalska, Piero Picci, Thomas Schmidt, Károly Szuhai, Pancras C.W. Hogendoorn	27
15	Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications 2014 ·PLoS ONE ·Ana Teresa Amaral, Maria Cristina Manara, Dagmar Berghuis, José Luis Ordóñez, Michele Biscuola, María Ángeles López‐García, Daniel Osuna, Enrico Lucarelli, Francesco Alviano, Arjan C. Lankester, Katia Scotlandi, Enrique de Álava	43
16	The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease 2012 ·SHILAP Revista de lepidopterología ·Dagmar Berghuis, Marco W. Schilham, Susy J. Santos, Suvi Savola, Helen J. Knowles, Uta Dirksen, Karl‐Ludwig Schaefer, Jukka Vakkila, Pancras C.W. Hogendoorn, Arjan C. Lankester	37
17	Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients 2012 ·Cancer Immunology Immunotherapy ·Emilie P. Buddingh, (unknown), Dagmar Berghuis, Hans Gelderblom, Jakob Anninga, Pancras C.W. Hogendoorn, R. Maarten Egeler, Marco W. Schilham, Arjan C. Lankester	13
18	Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis 2012 ·SHILAP Revista de lepidopterología ·Dagmar Berghuis, Marco W. Schilham, (unknown), Susy J. Santos, Stephan Kloeß, Emilie P. Buddingh, R. Maarten Egeler, Pancras C.W. Hogendoorn, Arjan C. Lankester	60
19	Pro‐inflammatory chemokine–chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8⁺ T‐lymphocyte infiltration and affect tumour progression 2010 ·The Journal of Pathology ·Dagmar Berghuis, Susy J. Santos, Hans J. Baelde, Antonïe H.M. Taminiau, R. Maarten Egeler, Marco W. Schilham, Pancras C.W. Hogendoorn, Arjan C. Lankester	115
20	Reduced human leukocyte antigen expression in advanced‐stage Ewing sarcoma: implications for immune recognition 2009 ·The Journal of Pathology ·Dagmar Berghuis, (unknown), Susy J. Santos, Daniëlle Horst, Emmanuel J. H. J. Wiertz, (unknown), Peter J. van den Elsen, Antonïe H.M. Taminiau, (unknown), Karl‐Ludwig Schaefer, Uta Dirksen, Erik Hooijberg, Arend Mulder, Cornelis J.M. Melief, R. Maarten Egeler, Marco W. Schilham, Ekaterina S. Jordanova, Pancras C.W. Hogendoorn, Arjan C. Lankester	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact